Sinopharm Group Co Ltd ($1099) - buy or sell? Stock discussion, ideas, forum

Sinopharm Group Co Ltd

Sinopharm Group Co is a pharmacy distribution company.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$1099	HKEx Main Board	CNE100000FN7	Code: 1099

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 1099 stock

Share your investment idea or question on Sinopharm Group Co Ltd stock:

Latest twits on Sinopharm Group Co Ltd (1099)

No twits yet. Be the first to post!

Have a question about 1099? Ask and other investors will be eager to help you.

Have an idea about 1099? Share it with other investors.

Sinopharm Group Co Ltd news

26/03/2018 Sinopharm Group Co Ltd EBITDA jumped on 14.5% and EBITDA Margin showed almost no change

24/03/2017 Sinopharm Group Co Ltd revenue growth continued to 13.8% in FY2016 vs. 13.5% a year earliner

28/03/2016 Sinopharm Group Co Ltd reports 17.0% EBITDA growth and 13.5% Revenue growth

30/03/2015 Sinopharm Group Co Ltd demonstrates profitable growth

Sinopharm Group Co Ltd stock price chart

Sinopharm Group Co Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	69,234	102,225	136,502
EBITDA	2,709	4,096	5,436
Net income	1,209	1,561	1,979
CAPEX	1,516	1,101	1,422
Debt	3,435	13,849	16,140
Cash	7,475	13,091	9,802

Sinopharm Group Co Ltd news

About Sinopharm Group Co Ltd

Sinopharm Group Co is a pharmacy distribution company. The Company also owns several pharmacy enterprise groups in different industries such as logistics, retail stores, pharmaceutical manufacturing, and chemical testing.